Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
25 hedge funds and large institutions have $41.6M invested in Augmedix, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 3 reducing their positions, and 1 closing their positions.
333% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 3
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
14% more funds holding
Funds holding: 22 → 25 (+3)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
36% less capital invested
Capital invested by funds: $64.9M → $41.6M (-$23.3M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samjo Capital
New York
|
+$868K |
| 2 |
Russell Investments Group
London,
United Kingdom
|
+$764K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
+$305K |
| 4 |
TC
TownSquare Capital
Provo,
Utah
|
+$153K |
| 5 |
SRAM
Spouting Rock Asset Management
Bryn Mawr,
Pennsylvania
|
+$147K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$58K |
| 2 |
Boston Partners
Boston,
Massachusetts
|
-$23.8K |
| 3 |
William Blair & Company
Chicago,
Illinois
|
-$21K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$16.6K |
AUGX Hedge Fund Activity: Q2 2022 in Review
25 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q2 2022, worth a combined $41.6M — down 36% from $64.9M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AUGX positions and 1 closed out — a net gain of 3 holders — while 13 added to existing stakes and 3 trimmed.
The largest buyer was Samjo Capital, adding an estimated $868K. The largest seller was Millennium Management, exiting entirely with an estimated $58K sold.
- 25 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q2 2022, up from 22 in Q1 2022.
- Funds reported $41.6M of Augmedix, Inc. Common Stock stock for Q2 2022, down 36% quarter-over-quarter.
- 4 funds opened new Augmedix, Inc. Common Stock positions in Q2 2022 and 1 closed out, a net change of +3 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q2 2022 was Samjo Capital, an estimated $868K added.
- The largest Augmedix, Inc. Common Stock seller in Q2 2022 was Millennium Management, an estimated $58K sold.
Based on aggregated 13F filings for Q2 2022.